Hodgkin lymphoma in temporal association with growth hormone replacement

Renee J. Freedman, Vera Malkovska, Derek LeRoith, Michael T. Collins

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


The association between growth hormone (GH) replacement and malignancy has long been debated. We report a case of Hodgkin lymphoma that developed in temporal association with the initiation of GH replacement in a 57-year-old woman with panhypopituitarism secondary to a non-secretory pituitary macroadenoma. Treatment of her pituitary tumor included transphenoidal surgery, external beam radiation, Bromocriptine and Cabergaline therapy. In addition to replacement steroid, thyroid and sex hormones, she insisted on GH replacement. Approximately 2 years after GH initiation, the diagnosis of Hodgkin lymphoma was made. Although the exact contribution of GH to the development of Hodgkin disease in our patient is unclear and a causal effect cannot be concluded, the temporal association is suggestive, and warrants reporting as part of ongoing surveillance for potential complications of GH replacement.

Original languageEnglish
Pages (from-to)571-575
Number of pages5
JournalEndocrine Journal
Issue number5
StatePublished - 2005
Externally publishedYes


  • Hematology
  • Hormones
  • Malignancy
  • Panhypopituitary


Dive into the research topics of 'Hodgkin lymphoma in temporal association with growth hormone replacement'. Together they form a unique fingerprint.

Cite this